We(Organon) are an independent global healthcare company with a strategy to improve the health of women throughout their lives. Our diverse portfolio across women's health, biosimilars, and established brands includes therapies and products for a wide range of conditions and diseases.
Our portfolio encompasses more than 60 medicines and devices across a range of areas including reproductive health, cardiovascular disease, neurology, autoimmune, and respiratory conditions. We bring these important therapies to more than 150 markets around the world.
We imagine a world where women, the backbone of a thriving and resilient society, can readily access solutions which meet her health needs. A world where she prospers, and so does her family, her community, and her world for generations to come. Together, we are building a brighter future for her.